The effects of angiotensin on respiratory patterns of anaesthetized dogs. 1981

I E Alexander, and E R Lumbers

The effects of a pressor dose of angiotensin II on the respiratory pattern of chloralose anaesthetized mongrel dogs was studied. In addition, since the hypertensive action of angiotensin II stimulates baroreflex pathways, the effects on breathing of baroreceptor stimulation were examined using aortic balloon inflation and i.v. phenylephrine. In the baroreceptor-denervated dog, i.v. angiotensin II was associated with a reduction in both inspiratory and expiratory time while both inspiration and expiration proceeded more quickly. Thus breathing became deeper and more rapid. Most of these effects of angiotensin II were opposite to the effects of hypertension caused by phenylephrine and aortic balloon inflation. These two forms of hypertension caused an increase in inspiratory and expiratory time, a decrease in the rate at which inspiration proceeded and a fall in tidal volume. These effects were not seen in baroreceptor denervated animals. In the intact dog angiotensin II caused a marked vagal dependent fall in tidal volume and inspiratory time while the rates at which inspiration and expiration proceeded were unaffected. It is concluded that angiotensin II has three independent effects on respiration. These are a respiratory depressant effect due to stimulation of baroreflex pathways by its pressor action, a 'central' stimulatory effect and an effect on the vagal control of inspiratory time.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D011311 Pressoreceptors Receptors in the vascular system, particularly the aorta and carotid sinus, which are sensitive to stretch of the vessel walls. Baroreceptors,Receptors, Stretch, Arterial,Receptors, Stretch, Vascular,Stretch Receptors, Arterial,Stretch Receptors, Vascular,Arterial Stretch Receptor,Arterial Stretch Receptors,Baroreceptor,Pressoreceptor,Receptor, Arterial Stretch,Receptor, Vascular Stretch,Receptors, Arterial Stretch,Receptors, Vascular Stretch,Stretch Receptor, Arterial,Stretch Receptor, Vascular,Vascular Stretch Receptor,Vascular Stretch Receptors
D012119 Respiration The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration ( Breathing
D003714 Denervation The resection or removal of the nerve to an organ or part. Laser Neurectomy,Neurectomy,Peripheral Neurectomy,Radiofrequency Neurotomy,Denervations,Laser Neurectomies,Neurectomies,Neurectomies, Laser,Neurectomies, Peripheral,Neurectomy, Laser,Neurectomy, Peripheral,Neurotomies, Radiofrequency,Neurotomy, Radiofrequency,Peripheral Neurectomies,Radiofrequency Neurotomies
D004106 Dilatation The act of dilating. Dilation,Dilatations,Dilations
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

I E Alexander, and E R Lumbers
March 1962, Archives internationales de pharmacodynamie et de therapie,
I E Alexander, and E R Lumbers
May 1989, Quarterly journal of experimental physiology (Cambridge, England),
I E Alexander, and E R Lumbers
July 1995, British journal of pharmacology,
I E Alexander, and E R Lumbers
September 1970, British journal of pharmacology,
I E Alexander, and E R Lumbers
August 1982, Naunyn-Schmiedeberg's archives of pharmacology,
I E Alexander, and E R Lumbers
December 1988, Clinical and investigative medicine. Medecine clinique et experimentale,
I E Alexander, and E R Lumbers
August 1999, Zentralblatt fur Veterinarmedizin. Reihe A,
Copied contents to your clipboard!